183 related articles for article (PubMed ID: 32278849)
1. Ductal Carcinoma In Situ Biology, Language, and Active Surveillance: A Survey of Breast Radiologists' Knowledge and Opinions.
Grimm LJ; Destounis SV; Rahbar H; Soo MS; Poplack SP
J Am Coll Radiol; 2020 Oct; 17(10):1252-1258. PubMed ID: 32278849
[TBL] [Abstract][Full Text] [Related]
2. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
3. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
[No Abstract] [Full Text] [Related]
4. Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ.
Théberge I; Vandal N; Perron L; Guertin MH
Breast Cancer Res Treat; 2021 May; 187(1):255-266. PubMed ID: 33392846
[TBL] [Abstract][Full Text] [Related]
5. Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs.
Nguyen DL; Greenwood HI; Rahbar H; Grimm LJ
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330503. PubMed ID: 38090808
[TBL] [Abstract][Full Text] [Related]
6. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
[TBL] [Abstract][Full Text] [Related]
7. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
[TBL] [Abstract][Full Text] [Related]
8. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
9. Identifying Good Candidates for Active Surveillance of Ductal Carcinoma
Glencer AC; Miller PN; Greenwood H; Maldonado Rodas CK; Freimanis R; Basu A; Mukhtar RA; Brabham C; Kim P; Hwang ES; Rosenbluth JM; Hirst GL; Campbell MJ; Borowsky AD; Esserman LJ
Cancer Res Commun; 2022 Dec; 2(12):1579-1589. PubMed ID: 36970720
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
[TBL] [Abstract][Full Text] [Related]
11. Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.
Selvakumaran V; Hou R; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Lu LX; Devalapalli A; Kim C; Soo MS; Hwang ES; Lo JY; Grimm LJ
Acad Radiol; 2020 Nov; 27(11):1580-1585. PubMed ID: 32001164
[TBL] [Abstract][Full Text] [Related]
12. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
13. Breast Radiologists' Perceptions on the Detection and Management of Invasive Lobular Carcinoma: Most Agree Imaging Beyond Mammography Is Warranted.
Coffey K; Berg WA; Dodelzon K; Jochelson MS; Mullen LA; Parikh JR; Hutcheson L; Grimm LJ
J Breast Imaging; 2024 Apr; 6(2):157-165. PubMed ID: 38340343
[TBL] [Abstract][Full Text] [Related]
14. Should low-risk DCIS lose the cancer label? An evidence review.
Ma T; Semsarian CR; Barratt A; Parker L; Pathmanathan N; Nickel B; Bell KJL
Breast Cancer Res Treat; 2023 Jun; 199(3):415-433. PubMed ID: 37074481
[TBL] [Abstract][Full Text] [Related]
15. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Elshof LE; Tryfonidis K; Slaets L; van Leeuwen-Stok AE; Skinner VP; Dif N; Pijnappel RM; Bijker N; Rutgers EJ; Wesseling J
Eur J Cancer; 2015 Aug; 51(12):1497-510. PubMed ID: 26025767
[TBL] [Abstract][Full Text] [Related]
17. Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment.
Shehata M; Grimm L; Ballantyne N; Lourenco A; Demello LR; Kilgore MR; Rahbar H
J Breast Imaging; 2019 Sep; 1(3):166-176. PubMed ID: 31538141
[TBL] [Abstract][Full Text] [Related]
18. Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype.
Slanetz PJ; Giardino AA; Oyama T; Koerner FC; Halpern EF; Moore RH; Kopans DB
Breast J; 2001; 7(6):417-21. PubMed ID: 11843854
[TBL] [Abstract][Full Text] [Related]
19. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
20. Active Surveillance for Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ.
Miceli R; Mercado CL; Hernandez O; Chhor C
J Breast Imaging; 2023 Jul; 5(4):396-415. PubMed ID: 38416903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
